Adrenal Insufficiency
📧 Sign up to get email alerts when something new happens for Adrenal Insufficiency.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-02EMA Authorised: Alkindi (hydrocortisone) — Immedica Pharma AB
EMA authorises Alkindi (hydrocortisone) for adrenal insufficiency, expanding treatment options.
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Adrenal Function in Critical Illness
The clinical trial NCT00156767 investigating adrenal function in critical illness conducted by NIDDK has completed.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: Evaluation of Children With Endocrine and Metabolic-Related Conditions
A NICHD-sponsored pediatric clinical trial evaluating endocrine and metabolic-related conditions is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Effect of Supplemental Hydrocortisone During Stress in Prednisolone-induced Adrenal Insufficiency [Phase 4]
Phase 4 clinical trial evaluating supplemental hydrocortisone during stress in patients with prednisolone-induced adrenal insufficiency; cur…
-
EMA approval · 2026-03-10EMA Authorised: Alkindi (hydrocortisone) — Immedica Netherlands B.V.
The EMA authorised Alkindi (hydrocortisone) by Immedica Netherlands B.V. for adrenal insufficiency.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Updated Diagnostic Cortisol Values for Adrenal Insufficiency [NA]
A clinical trial registry entry notes updated diagnostic cortisol value criteria for adrenal insufficiency and the study is currently recrui…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function [NA]
This completed clinical trial assessed the use of glucagon-like peptide-1 receptor agonists to evaluate adrenal function and HPA axis respon…
-
CLINICAL_TRIALS research · 2026-01-26Clinical Trial Update: Risks of Ramadan Fasting in Patients With Primary Adrenal Insufficiency Treated With Prednisolone. [NA]
Clinical trial update highlighting the risks of Ramadan fasting in patients with primary adrenal insufficiency treated with prednisolone, in…
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Hydrocortisone and Placebo in Patients With Symptoms of Adrenal Insufficiency After Cessation of Glucocorticoid Treatment [Phase 4]
Phase 4 clinical trial evaluating hydrocortisone versus placebo in patients with symptoms of adrenal insufficiency after stopping glucocorti…
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: Establishment and Clinical Application of Reference Intervals of Salivary Cortisol
The trial aims to establish reference intervals for salivary cortisol and assess their clinical application in healthy adults and patients w…
-
CLINICAL_TRIALS research · 2025-08-28Clinical Trial Update: Early Psychological Intervention After Rape [NA]
This clinical trial evaluates an early psychological intervention after rape, with recruitment currently ongoing.
-
CLINICAL_TRIALS research · 2025-08-20Clinical Trial Update: A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement
A clinical trial update evaluating a block-and-replace strategy using Osilodrostat with concurrent glucocorticoid replacement for endogenous…
-
CLINICAL_TRIALS research · 2025-08-01Clinical Trial Update: Study on the Incidence of Adrenal Insufficiency After Surgery in Primary Aldosteronism Patients Concurrent With or Without Autonomous Cortisol Secretion
A clinical trial is recruiting to determine how often adrenal insufficiency occurs after surgery in patients with primary aldosteronism, wit…
-
FDA approval · 2025-05-28FDA Approved: KHINDIVI — Original Application (Eton Pharmaceuticals, Inc.)
FDA approved KHINDIVI (hydrocortisone) through an original NDA submitted by Eton Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2025-05-20Clinical Trial Update: Continuous Steroid Monitoring in Interstitial Fluid With Wearable and Nanoparticle-enhanced Biosensors for Improved Management of Adrenal Disorders [NA]
This study investigates continuous monitoring of steroid levels in interstitial fluid using a wearable sensor platform and nanoparticle-enha…
-
CLINICAL_TRIALS research · 2025-03-06Clinical Trial Update: A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
This ClinicalTrials.gov update describes a pediatric study at University Children's Hospital Basel evaluating how glucocorticoid therapy for…
-
CLINICAL_TRIALS research · 2025-02-18Clinical Trial Update: Ramadan Fasting Outcomes in Patients With Secondary Adrenal Insufficiency Before and After the Treatment of Hypotension. [Phase 4]
Phase 4 clinical trial evaluating Ramadan fasting outcomes in patients with secondary adrenal insufficiency before and after treatment for h…
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency [NA]
A completed clinical trial investigated the risks associated with intermittent fasting in patients with primary adrenal insufficiency. The u…
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Ramadan Fasting in Secondary Adrenal Insufficiency Patients [NA]
A clinical trial evaluating Ramadan intermittent fasting in patients with Secondary Adrenal Insufficiency has completed.
-
CLINICAL_TRIALS research · 2024-12-10Clinical Trial Update: Defining the Mechanisms Underlying Adrenal Insufficiency in Cirrhosis
A University of Virginia clinical trial investigates the mechanisms of adrenal insufficiency in cirrhosis. The study status is COMPLETED.
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: NeSST2: The Development of a Noninvasive Short Synacthen Test [Phase 2]
A Phase 2 study is developing a noninvasive short Synacthen test (NeSST2) to detect adrenal suppression and is currently recruiting.
-
FDA approval · 2024-11-25FDA Approved: HYDROCORTISONE — Original Application (Eywa Pharma Inc)
FDA approved HYDROCORTISONE from Eywa Pharma Inc under an Original Application (ANDA 217160). This entry documents the approval of a generic…
-
CLINICAL_TRIALS research · 2024-10-15Clinical Trial Update: Self-management in Patients With Adrenal Insufficiency.
A clinical trial in Region Stockholm is evaluating self-management in patients with adrenal insufficiency. It is currently active but not re…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI)
European post-authorization observational registry for patients with chronic adrenal insufficiency; the study has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-08-28Clinical Trial Update: Ultrasonographical of Suprarenal Gland in High Risk Neonates
A completed clinical trial (NCT06575504) from Al-Azhar University evaluating ultrasonography of the adrenal glands in high-risk neonates wit…